KAREN MONGER: Open Payments
NPI 1255720801 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,654 in 110 payments from 16 companies in 2025. Trend: 2023 $916 · 2024 $2,029 · 2025 $2,654
Food & beverage: $2,620Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 29 | $1,219 |
| GlaxoSmithKline, LLC. | 26 | $473 |
| Regeneron Healthcare Solutions, Inc. | 9 | $175 |
| Amgen Inc. | 11 | $155 |
| Viatris Specialty LLC | 9 | $142 |
| GENZYME CORPORATION | 3 | $77 |
| Electromed, Inc. | 6 | $75 |
| Verona Pharma, Inc. | 3 | $71 |
| Insmed, Inc. | 3 | $62 |
| Grifols USA, LLC | 3 | $59 |
Products named: TEZSPIRE, AIRSUPRA, FASENRA, NUCALA, DUPIXENT, TRELEGY ELLIPTA, BREZTRI, YUPELRI.
Industry payments across NC — which companies pay providers there.
